Table 2.
ΔCT(MDH-gene) | ΔCT(MDH-gene) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Gene | Control | PGE2 incubation |
P | Gene | Control | PGE2 incubation |
P | ||||
mean | sd | mean | sd | mean | sd | mean | sd | ||||
Genes affected by chronic COX inhibition in utero | Genes un-affected by chronic COX inhibition in utero | ||||||||||
CaLα1c | −0.24 | ±0.49 | 0.59 | ±0.54 | * | BKCa | −7.13 | ±0.98 | −7.27 | ±0.55 | |
CaLβ2 | −2.31 | ±1.01 | −1.33 | ±0.83 | * | COX2 | 0.77 | ±0.96 | 1.06 | ±1.36 | |
CaLβ3 | −1.28 | ±0.38 | −1.12 | ±0.31 | EP2 | −1.86 | ±0.43 | −1.96 | ±0.85 | ||
Caldesmon | 1.12 | ±0.78 | 1.11 | ±0.63 | EP3 | −5.44 | ±1.03 | −4.99 | ±0.98 | ||
BKCaβ1 | −4.40 | ±0.26 | −4.06 | ±0.44 | ET1 | −4.52 | ±1.33 | −4.74 | ±1.22 | ||
HO1 | −2.08 | ±0.38 | −1.59 | ±0.47 | * | PDGF−B | −3.95 | ±0.83 | −3.91 | ±0.71 | |
Kir6.1 | −5.21 | ±1.00 | −4.31 | ±0.92 | * | RhoA | 1.87 | ±0.41 | 2.07 | ±0.39 | |
Kv1.5 | −1.99 | ±1.40 | −0.96 | ±0.87 | * | RhoB | 2.42 | ±0.61 | 2.80 | ±0.78 | |
Myocardin | −3.40 | ±0.47 | −3.29 | ±0.77 | ROCK1 | −2.82 | ±0.75 | −2.49 | ±0.59 | ||
PDE1A | −5.79 | ±1.02 | −4.72 | ±0.95 | * | SUR2 | −1.04 | ±0.41 | −0.78 | ±0.55 | |
PDE3A | −2.58 | ±0.66 | −1.62 | ±0.96 | * | ||||||
Tenascin-C | 1.00 | ±0.81 | 0.64 | ±1.18 | |||||||
TGFβ1 | −0.61 | ±0.34 | −0.35 | ±0.31 | |||||||
TGFβ3 | −4.09 | ±0.76 | −3.76 | ±0.64 | |||||||
Tropomyosin | −0.25 | ±1.01 | −0.50 | ±0.58 | |||||||
VEGF | 0.31 | ±0.72 | 1.61 | ±0.86 | * |
Rings from the same sheep ductus were incubated with or without PGE2 (10−8 M) for 20 hours. We examined the expression of genes that were altered by chronic COX inhibition in utero in Table 1; we also examined the expression of several of the genes that were not affected by chronic COX inhibition (see Table 1). Number of separate animals used = 7.
p<0.05.